LEBOVITS CHAIM (See Remarks) received a stock award from BRAINSTORM CELL THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 4/19/2024ACC: 0001104659-24-049027
Officer· See Remarks
Since Jul 2018
+245.07K
Net shares
Net buyer
$131.4K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
245.07K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+130K
Price / share
$0.55
Trade value
$70.94K
% of position
21.7%
4/17/2024
598.49K→728.49K
Common Stock
Direct
Shares
+115.07K
Price / share
$0.53
Trade value
$60.47K
% of position
15.8%
4/18/2024
728.49K→843.57K
Total
Net shares
+245.07K
Net value
$131.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/17/2024 | A · Award | +130K | $0.55 | $70.94K | 21.7% | 598.49K | 728.49K |
| Common Stock Direct | 4/18/2024 | A · Award | +115.07K | $0.53 | $60.47K | 15.8% | 728.49K | 843.57K |
| Total | +245.07K | $131.41K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2M
Total
2M indirect2M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2M | Indirect |
| Total | 2M | 2M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported